It is the target of several US FDA approved anti-diabetic medications, such as: These drugs block the degradation of incretins (GLP-1 and GIP) by DPP-4, and potentiate insulin secretion following food intake
There is a practical compounding wrinkle worth understanding conceptually
Tirzepatide met both co-primary endpoints during the 72-week double-blind treatment period, demonstrating the superiority of the drug over placebo
However, it remains an investigational regimen and is not an approved treatment
Pros of Online GLP-1 Services: Cons of Online GLP-1 Services: Endocrinologists are medical specialists with extensive training in hormone-related disorders, including diabetes and obesity
Healthcare should be a partnership, not a permission slip, and proactive care is just as essential as treatment